Giulia Scagnetti

Thesis/Dissertation

Scagnetti G. 2023. Investigating the Sensitivity of Non-Small Cell Lung Cancer to Cisplatin using MicroRNA-184 loaded Chitosan Nanocarriers Saleem I, Ross K, Michael D, Liloglou L. Public Url

Poster

Scagnetti G, Ross K, Saleem I. 2021. microRNA-184 mimic delivery via microfluidic-based chitosan nanoparticles: a potential tool to tackle cisplatin resistance in NSCLC RNA 2021 (Online conference)

Scagnetti G, Ross K, Carini V, Davies, M , Liloglou T, Saleem I. 2019. Water-soluble Chitosan Nanoparticles Loaded with miRNA-mimics to overcome Cisplatin Resistance in Non-small Cell Lung Carcinoma EACR Nanotechnology in Cancer: Engineering for Oncology, Cambridge, UK.

Chapters

Kaneko K, Osman NM, Carini V, Scagnetti G, Saleem IY. 2020. Overview of the Advantages and Disadvantages of Different Mucosal Sites for the Delivery of Nanoparticles Muttil P, kunda N. Mucosal Delivery of Drugs and Biologics in Nanoparticles 41 Springer Nature DOI Publisher Url Public Url

Conference publication

Carini V, Esenturk I, Scagnetti G, Saleem I. PREPARATION AND OPTIMIZATION OF CHITOSAN NANOPARTICLES THROUGH MIROFLUIDICS MIXING TECHNOLOGY 2018 UKICRS Workshop & Symposium

Scagnetti G, Verhook S, Killoran P, Coxon C, Osman N, Gordon S, Chaudary S, Saleem I. Antimicrobial Activity of Peptide Aurein 3.1 Complexed in Chitosan Nanoparticle for Pulmonary Delivery - 11th PBP World Meeting

Conference presentation:

microRNA-184 mimic delivery via microfluidicbased chitosan nanoparticles: a potential tool to tackle cisplatin resistance in NSCLC, RNA 2021, Online, Poster presentation. 2021